Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
93.07 | 8.5% | 21.92% | 189,900.62 | 3.57% | 4.67% |
|
NYSE:PFE
Pfizer
|
28.44 | 9.18% | 39.63% | 161,157.9 | 6% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
92.71 | 14.77% | 33.02% | 115,761.94 | 3.99% | 8.19% |
|
TSE:4568
Daiichi Sankyo Company
|
5422.00 | 0% | 0% | 10,393,676.28 | 1.11% | 0% |
|
NasdaqGS:MRNA
Moderna
|
125.67 | -,111.33% | -,107.82% | 48,161.74 | 0% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4102.00 | 0% | 0% | 6,435,766.66 | 4.75% | 0% |
|
NasdaqGS:BIIB
Biogen
|
225.34 | -13.26% | 2.13% | 32,808.8 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
29.38 | 62.97% | 78.88% | 28,863.62 | 0.38% | 1.47% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
149.89 | 0% | 0% | 18,959.85 | 0% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.50 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NasdaqGS:SRPT
Sarepta Therapeutics
|
131.70 | 0% | 0% | 12,505.49 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
108.05 | 0% | 0% | 6,783.92 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
38.80 | -,156.68% | -,149.23% | 5,756.54 | 0% | 0% |
|
NasdaqGS:DYN
Dyne Therapeutics
|
26.62 | 0% | 0% | 2,267.58 | 0% | 0% |
|
TSE:4516
Nippon Shinyaku
|
3893.00 | 0% | 0% | 297,901.34 | 2.8% | 0% |
|
NasdaqGM:WVE
Wave Life Sciences
|
5.69 | 0% | 0% | 688.23 | 0% | 0% |
|
NasdaqGS:STOK
Stoke Therapeutics
|
11.55 | 0% | 0% | 604.59 | 0% | 0% |
|
NasdaqGS:ABUS
Arbutus Biopharma
|
2.89 | 0% | 0% | 535.96 | 0% | 0% |
|
NasdaqGM:FULC
Fulcrum Therapeutics
|
7.35 | 0% | 0% | 456.83 | 0% | 0% |
|
ASX:PYC
PYC Therapeutics
|
0.10 | 0% | 0% | 294.9 | 0% | 0% |
